Hendra

H2 Power Co. Taps Ford Motor Co. Leader Melissa Hendra to Join All-Star Hydrogen Team

Retrieved on: 
Wednesday, September 6, 2023
Hydrogen, Ford Motor Company, Special Olympics, Department of transportation, Transport, Hendra, Government, EPA, Indian Olympic Association, R, Melissa, Tank, Department of Defence, Gasoline

ENGLEWOOD, Colo., Sept. 6, 2023 /PRNewswire/ -- Ford Motor Co. veteran Melissa Hendra joins the H2 Power Co. bringing 28 years of experience with Ford's Research & Advanced Engineering (R&A) organization managing government contracts. Hendra joins Ford Motor Co. veterans Soraya Kim Larkin, Jeff Hepburn, and Fred Brighton. "With infrastructure investment funds available, adding Melissa will allow us to capitalize on her numerous years of experience in navigating government contracts," says Larkin. "This is an integral part of our fast growth plan."

Key Points: 
  • Ford Motor Co. Leader and Government Contract expert Melissa Hendra joins H2 Power Co.'s team to advance hydrogen power accessibility.
  • ENGLEWOOD, Colo., Sept. 6, 2023 /PRNewswire/ -- Ford Motor Co. veteran Melissa Hendra joins the H2 Power Co. bringing 28 years of experience with Ford's Research & Advanced Engineering (R&A) organization managing government contracts.
  • Hendra joins Ford Motor Co. veterans Soraya Kim Larkin, Jeff Hepburn, and Fred Brighton.
  • Also, I thrive on negotiations, and I look forward to joining the H2 Power team to bring hydrogen charging solutions to market," says Hendra.

EQS-News: Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics

Retrieved on: 
Friday, June 2, 2023
Vaccine, Human, Therapy, Hendra virus, Nipah virus, Frankfurt Stock Exchange, Global health, Research, RNA, Hendra, Open Philanthropy (organization), Henipavirus, ISIN, World Health Organization, R, EVO

Evotec SE (Frankfurt Stock Exchange: EVT, ISIN: DE0005664809; NASDAQ: EVO) today announced that the Company has received a $ 1.7 m grant from Open Philanthropy, a philanthropic funder prioritising global health and wellbeing.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, ISIN: DE0005664809; NASDAQ: EVO) today announced that the Company has received a $ 1.7 m grant from Open Philanthropy, a philanthropic funder prioritising global health and wellbeing.
  • Under the grant, Evotec aims to discover and develop RNA-targeting small molecules as potential first-in-class therapeutics against Henipaviruses.
  • The genus comprises six different established species including Hendra virus and Nipah virus, from which it receives its name.
  • This is the first time that we have been supported by Open Philanthropy and we are very excited about this opportunity.